PRINCETON, N.J., Nov. 3, 2005 (PRIMEZONE) -- The Bull Market Report (http://www.bullmarket.com), a long-term growth and income-generating focused online investment newsletter, announced today that it has provided subscribers with a detailed look at several conglomerates including Leucadia National (NYSE:LUK), Dover (NYSE:DOV), Cendant (NYSE:CD), and Tyco (NYSE:TYC).
All paid and trial subscribers to The Bull Market Report can now receive immediate access to The Bull Market Report's exclusive daily reports. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR55
In discussing Tyco, The Bull Market Report wrote, "Yes, the global economy has soft spots -- it always does. However, Tyco has the products and global reach to crank up growth in the most opportune areas of the market. Simply put, when you mix a good management team with resources like Tyco's, you set the stage for a lot of good things to happen, both in operations and in terms of the company's financial strength."
In its recent stock market coverage, The Bull Market Report looked at the following topics, among many others:
-- What will Leucadia's success hinge upon in the coming year?
-- What strengths does Dover possess that make it look like an
attractive investment?
-- What type of value does it look like Cendant could fetch if it
splits up its businesses?
-- What price target has The Bull Market Report placed on Tyco?
About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Bull Market Report's Recommended List includes over 50 companies across all major industries, including financials, healthcare, energy, technology, and retail, among others. As a testament to the durability of its value-focused and fundamentally sound recommendations in both up and down markets, The Bull Market Report is one of the oldest continuously published investment newsletters online. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR55
Subscribers also receive access to The Bull Market Report's special bonus reports, "Search Sector Outlook," "Biotech Sector Outlook," and "Understanding the Value of Insider Trading Data."
Note: This release was published by Indie Research, LLC (CRD #131926). Indie Research, LLC and The Bull Market editorial staff are not registered investment advisors, broker/dealers, or research analysts/organizations.